[#item_full_content] As a global medical cannabis leader, Tilray Medical supports continued policy development that strengthens physician confidence, protects patient access and provides a clear, sustainable framework for medical cannabis in Germany. The guidance issued by the KBV and GKV-Spitzenverband represents an important step forward by providing greater practical direction for the prescribing of standardized full-spectrum cannabis extracts. Tilray Medical welcomes this progress and encourages policymakers to 
Read More
Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
ByPot Shop News
August 18, 2026